Mixed trend on the daily chart: above its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Sep 16 · inside the Ichimoku cloud · RSI 13 (oversold) · MACD above its signal · at its 52-week low
None of the 29 investors followed here reported a position in CLABF in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a CLABF trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for CLABF.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% | ||
| 2025 | -58.8 | 52.5 | 59.1 | -54.9 | 97.0 | -31.2 | -59.6 | 40.1 | -43.7 | -99.4 | 0.0 | -90.0 | −100.0% |
| 2024 | -5.9 | -24.4 | -5.8 | -3.9 | -3.5 | -30.4 | -5.3 | 14.5 | -46.4 | 62.9 | 2.3 | -10.0 | −62.3% |
| 2023 | 2.7 | -21.5 | -16.9 | -0.9 | -11.0 | -7.2 | 52.8 | -28.0 | -5.2 | -26.1 | -17.7 | 38.3 | −51.9% |
| 2022 | 76.6 | -16.4 | -11.5 | -18.3 | -35.4 | -18.2 | -17.3 | 49.9 | 21.4 | 51.9 | 5.5 | -32.8 | −8.5% |
| 2021 | 12.1 | 16.5 | -10.2 | -12.9 | -19.9 | -17.1 | 16.4 | -42.8 | -41.8 | -15.4 | -39.1 | -28.8 | −90.4% |
| 2020 | 5.9 | -39.8 | -22.3 | -17.4 | -1.4 | 83.5 | 15.8 | 0.0 | 0.0 | 0.0 | 0.0 | 32.4 | +13.5% |
| 2019 | 54.5 | 0.3 | -17.5 | 51.9 | -33.6 | -4.3 | -39.7 | -39.0 | -15.4 | -42.1 | 114.8 | -50.3 | −76.3% |
| 2018 | -31.1 | -25.1 | 4.2 | 2.9 | 10.9 | -4.7 | -19.0 | -19.5 | -8.7 | -17.7 | -2.1 | -24.8 | −78.9% |
| 2017 | -9.3 | -6.5 | 2.1 | -6.5 | 8.8 | 18.9 | -24.8 | -12.2 | -0.1 | 4.0 | 43.5 | 107.8 | +114.7% |
| 2016 | 0.0 | 0.0 | 0.0 | 26.1 | -18.8 | -20.3 | 0.0 | 188.4 | 153.4 | 55.6 | -17.1 | -18.6 | +526.0% |
| 2015 | -54.8 | 40.8 | -58.0 | 0.0 | 0.0 | 83.3 | −51.0% |
No analyst coverage for this instrument.
Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and operates medical clinics, as well as engages in micro cultivation. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
No recent headlines.